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Vagal nerve stimulation (VNS) as described in the National
Institute of Clinical Excellence (NICE) guidelines on the manage-
ment of Epilepsy1 is indicated for use as an adjunctive therapy in
reducing the frequency of seizures in children, young adults and
adults2 who are refractory to antiepileptic drug (AED) therapy but
who are not suitable for resective surgery. It has been reported to
be both effective and safe. The Federal Drug Agency in US has
approved its use as a treatment option in patients over the age of
12 who have refractory epilepsy and are not candidates for surgical
resection.3
Montavont and Ryvlin4 described that the antiepileptic efﬁcacy
of VNS in intractable cases was remarkably consistent among their
series of patients, with an average decrease in seizure frequency of
40%. They suggested a 50% responder rate (i.e. the proportion of
patients whose seizure frequency declined by at least 50%) and a
proportion of seizure-free patients below 5%.
VNS involves a small operation to implant under the skin a
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the skin.
Parasympathetic innervations of the heart are controlled by the
Vagus nerve. The Vagus nerve when stimulated acts to lower the
heart rate. The right Vagus innervates the Sinoatrial (SA) node and
when there is parasympathetic hyper stimulation it predisposes
those affected to bradyarrhythmias. The left Vagus innervates the
atrioventricular (AV) node and when hyper stimulated predisposes
the heart to AV blocks.
VNS is generally well tolerated and safe, but there have been
cases reported of bradycardia occurring intraoperatively and
clinically.5,6 We came across a few reports, one of which described
a delayed intractable bradycardia resulting from a Vagus nerve
under traction by tethered stimulator leads7 and three other case
reports of late onset cardiac arrhythmia post VNS, one occurring in
a 17 year old young man 2 years and 4 months post VNS,8 another
occurring in a 13 year old boy 6 and a half years post VNS9 and the
last occurring in a 47 year old woman 9 years post VNS.10 None of
these cases were reported to have an intellectual disability. We
report a case of a 55 year old man with intellectual disability who
about 8 years later developed an iatrogenic ventricular asystole
presenting as recurrent cardiogenic syncope following VNS which
was initially misdiagnosed as his seizure worsening.
2. Case report
This is a case of a 55 year old man with intellectual disability
and partial seizure with secondary generalisation as well as drop
attacks (atonic seizures), secondary to a cerebral anoxic brain
damage during his perinatal period. He was managed on a variety
of AED treatments over the years and his epilepsy was eventually
assessed as being refractory to AED treatment. He was then offered
a VNS in 2003. His AED’s at the time included Levetiracetam
3000 mg/day and Oxcarbazepine 1200 mg/day and his seizure
frequency was averaging about 70 per month inclusive of both
seizure types.
His VNS workup did not reveal any cardiac problems. His VNS
was ﬁtted following usual procedures. The required intraoperative
tests were performed and no complications were noted. Following
his VNS being ﬁtted his seizure frequency and intensity of both
seizure types improved signiﬁcantly. Approximately 8 years later
there was an increase in what seemed to be atonic seizures which
started occurring on an almost daily basis, which given his historyvier Ltd. All rights reserved.
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was on at the time which included Levetiracetam 3000 mg/day and
Pregabalin 300 mg/day were adjusted and his VNS was checked
and titrated but there was no improvement in his seizures. A
detailed description of these events suggested that these attacks
were different from previous episodes and pointed at a cardiac
cause. An assessment of his cardiac status was then requested. No
electroencephalogram (EEG) was done to rule out the seizures as
interictal activity causing bradycardia or asystole.11
During review by his cardiologist he described an awareness of
his VNS ﬁring during which he developed feelings of lethargy and
pre-syncope which was occasionally followed by a loss of
consciousness for up to 2 min at a time. Initial physical
examination was normal. His pulse rate was 70 beats/min but
this fell to 40 beats/min during an observed episode when his VNS
ﬁred. His blood pressure was 146/98, with postural drop within
3 min of standing. Subsequent electrocardiogram (ECG) showed
sinus rhythm and was within normal limits.
There was a suspicion that the VNS was causing symptomatic
bradycardia and a 24 h cardiac monitor was arranged. This showed
recurrent episodes of ventricular standstills, pauses (Fig. 1) and
runs of complete heart block, the longest duration being 12.7 s.
During the bradycardia episodes and ventricular standstill the VNS
electrical impulses were clearly seen on the cardiac tracing.
Normal P wave activity continued during the episodes of
bradycardia, although at a slightly slower rate than the baseline
rate before the VNS was ﬁring. VNS setting output was 2.25 milli-
amp (mA), frequency 20 H, pulse width 250 ms, 30 s on and 3 min
off time.
At this point the VNS was deactivated, following discussion
with patient, his family and carers. A repeat 24 h cardiac monitor
was arranged, which showed this time around sinus rhythm
throughout. The only abnormality seen during this period of
monitoring was ﬁrst degree heart block, with a PR interval of
220 ms.
Approximately 2 months after the VNS was deactivated his
secondary generalised seizures worsened despite efforts to
optimise his AED treatment. Following another discussion with
the patient, his family and carers a decision was made to reactivate
his VNS again. This occurred 4 months after it was initially
deactivated. The VNS was turned on at an output of 0.25 mA (7 s on
time) and increased gradually by 0.25 mA every 3–4 days. At 1 mA
our patient unfortunately sustained recurrent syncope. A repeat
24 h cardiac monitoring showed signiﬁcant pauses of up to 9.79 s
(Fig. 2). Although the VNS output impulses were of much smaller
amplitude, they were still clearly visible on the cardiac trace andFig. 1. AV blocking on 24 h ECG pcorrelated with every episode of bradycardia or ventricular
standstill. The cardiac monitoring also showed continued P wave
activities but there were runs of ventricular asystole.
A consensus decision was made and the VNS was again
deactivated. Following discussion with his cardiologist, he was
offered the option of either a pacemaker insertion, followed by VNS
reactivation, or an increase in his AED therapy with the VNS
remaining deactivated. The patient opted for the latter. A 24 h EEG
was done after the VNS was deactivated the second time and
showed temporal sharp waves with right sided emphasis
suggesting epileptic activity. There were no typical drop attacks
captured during the recording.
3. Discussion
The reason for the ventricular asystole in our patient remains at
best obscured or speculative. Our patient had no prior history of
cardiac problems, his generator had been monitored at regular
intervals and the setting had not been changed in the months
before the recurrent syncope, no generator malfunction had been
detected and there had been no major changes in his AED
treatment such as the commencement of a new medication.
Asconape´ et al.6 described a case report of intraoperative
bradycardia and asystole and highlighted a number of possible
causes for their observation some of which included the placement
of the electrodes, aberrant anatomy and collateral stimulation of
the cervical cardiac nerves. If any of these were present in our
patient they should have occurred earlier during VNS treatment.
Amark et al.8 in a case report of a young man developing
bradyarrhythmia 2 years after VNS implantation could not identify
a speciﬁc cause for their observation.
It is our view that the ventricular asystole noted in our patient
was iatrogenic which like in our patient can be misdiagnosed as a
case of seizure worsening. This is especially an issue of concern in
vulnerable adults such as our patient who might have intellectual
disability and limited mechanisms of communication to express
their distress or provide relevant history or symptomology. As far
as we are aware there are only two other reports of ventricular
asystole occurring so late in VNS therapy.9,10
Although VNS is considered a safe option in refractory epilepsy
management it is important that clinicians should be aware of this
rare but late onset, potentially life threatening adverse effect of
VNS. It is our view that given the higher incidence of sudden death
in patients with refractory epilepsy,12 regular monitoring of
cardiac status might be called for in VNS ﬁtted patients especially if
there is a worsening in certain types.rior to 1st VNS deactivation.
Fig. 2. Longest ventricular pause on 24 h ECG after VNS reactivation.
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